HEADER ANTIBIOTIC 29-OCT-18 6MW0 TITLE MLE-PHE-MLE-D-PHE. LINEAR TETRAPEPTIDE RELATED TO PSEUDOXYLALLEMYCIN TITLE 2 A. COMPND MOL_ID: 1; COMPND 2 MOLECULE: MLE-PHE-MLE-D-PHE LINEAR TETRAPEPTIDE RELATED TO COMPND 3 PSEUDOXYLALLEMYCIN A; COMPND 4 CHAIN: A; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: XYLARIA; SOURCE 4 ORGANISM_TAXID: 37991 KEYWDS TETRAPEPTIDE, N-METHYL LEUCINE, PSEUDOXYLALLEMYCIN A, ANTIBIOTIC EXPDTA X-RAY DIFFRACTION AUTHOR A.J.CAMERON,P.W.R.HARRIS,M.A.BRIMBLE,C.J.SQUIRE REVDAT 2 23-OCT-24 6MW0 1 REMARK REVDAT 1 11-SEP-19 6MW0 0 JRNL AUTH A.J.CAMERON,C.J.SQUIRE,A.GERENTON,L.A.STUBBING,P.W.R.HARRIS, JRNL AUTH 2 M.A.BRIMBLE JRNL TITL INVESTIGATIONS OF THE KEY MACROLACTAMISATION STEP IN THE JRNL TITL 2 SYNTHESIS OF CYCLIC TETRAPEPTIDE PSEUDOXYLALLEMYCIN A. JRNL REF ORG.BIOMOL.CHEM. V. 17 3902 2019 JRNL REFN ESSN 1477-0539 JRNL PMID 30941386 JRNL DOI 10.1039/C9OB00227H REMARK 2 REMARK 2 RESOLUTION. 0.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 CROSS-VALIDATION METHOD : NONE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 41 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 7 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 ANGLE DISTANCES (A) : NULL REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: FULL LEAST SQUARES REFINEMENT IN SHELXL REMARK 3 WITH ANISOTROPIC DISPLACEMENT PARAMETERS AND HYDROGENS PLACED IN REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 6MW0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1000237717. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.71075 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4911 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.780 REMARK 200 RESOLUTION RANGE LOW (A) : 23.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 11.50 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.00 REMARK 200 R MERGE FOR SHELL (I) : 0.56700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING REMARK 200 SOFTWARE USED: SHELXS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 30.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: METHANOL, WATER, EVAPORATION, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 4.14550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 11.50800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 10.46550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 11.50800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 4.14550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 10.46550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 70 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 MLE-PHE-MLE-D-PHE. LINEAR TETRAPEPTIDE RELATED TO REMARK 400 PSEUDOXYLALLEMYCIN A. THIS PEPTIDE IS LINEAR, UNLIKE CYCLIC REMARK 400 PSEUDOXYLALLEMYCIN A, AND CONTAINS TERMINAL D-PHE, UNLIKE REMARK 400 PSEUDOXYLALLEMYCIN A THAT CONTAINS PHE. REMARK 400 REMARK 400 THE LINEAR TETRAPEPTIDE RELATED TO PSEUDOXYLALLEMYCIN A IS PEPTIDE- REMARK 400 LIKE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: LINEAR TETRAPEPTIDE RELATED TO PSEUDOXYLALLEMYCIN A REMARK 400 CHAIN: A REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6MVZ RELATED DB: PDB REMARK 900 ALL L- VERSION OF THIS PEPTIDE DBREF 6MW0 A 1001 1004 PDB 6MW0 6MW0 1001 1004 SEQRES 1 A 4 MLE PHE MLE DPN HET MLE A1001 18 HET MLE A1003 18 HET DPN A1004 24 HET MOH A1101 2 HETNAM MLE N-METHYLLEUCINE HETNAM DPN D-PHENYLALANINE HETNAM MOH METHANOL FORMUL 1 MLE 2(C7 H15 N O2) FORMUL 1 DPN C9 H11 N O2 FORMUL 2 MOH C H4 O FORMUL 3 HOH *7(H2 O) LINK C AMLE A1001 N APHE A1002 1555 1555 1.37 LINK C BMLE A1001 N BPHE A1002 1555 1555 1.34 LINK C APHE A1002 N AMLE A1003 1555 1555 1.35 LINK C BPHE A1002 N BMLE A1003 1555 1555 1.34 LINK C AMLE A1003 N ADPN A1004 1555 1555 1.30 LINK C BMLE A1003 N BDPN A1004 1555 1555 1.31 CRYST1 8.291 20.931 23.016 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.120613 0.000000 0.000000 0.00000 SCALE2 0.000000 0.047776 0.000000 0.00000 SCALE3 0.000000 0.000000 0.043448 0.00000 HETATM 1 N AMLE A1001 11.602 8.455 16.491 0.50 4.13 N ANISOU 1 N AMLE A1001 436 429 613 -5 -30 -109 N HETATM 2 N BMLE A1001 11.466 8.479 16.214 0.50 5.89 N ANISOU 2 N BMLE A1001 489 517 1099 27 -138 70 N HETATM 3 CN AMLE A1001 11.460 8.818 15.113 0.50 5.71 C ANISOU 3 CN AMLE A1001 749 569 723 -96 62 55 C HETATM 4 CN BMLE A1001 11.343 8.862 14.809 0.50 6.13 C ANISOU 4 CN BMLE A1001 638 679 875 3 -110 -145 C HETATM 5 CA AMLE A1001 10.306 8.231 17.200 0.50 4.98 C ANISOU 5 CA AMLE A1001 506 588 688 1 31 -150 C HETATM 6 CA BMLE A1001 10.225 8.290 17.023 0.50 5.15 C ANISOU 6 CA BMLE A1001 415 483 942 21 -126 70 C HETATM 7 CB AMLE A1001 10.553 7.749 18.628 0.50 5.85 C ANISOU 7 CB AMLE A1001 725 687 680 227 -54 -104 C HETATM 8 CB BMLE A1001 10.557 7.896 18.466 0.50 6.10 C ANISOU 8 CB BMLE A1001 355 688 1137 96 -53 291 C HETATM 9 CG AMLE A1001 9.296 7.088 19.172 0.50 7.71 C ANISOU 9 CG AMLE A1001 518 1413 823 384 6 65 C HETATM 10 CG BMLE A1001 9.386 7.670 19.495 0.50 6.48 C ANISOU 10 CG BMLE A1001 742 858 715 94 -2 -149 C HETATM 11 CD1AMLE A1001 9.446 6.971 20.701 0.50 10.07 C ANISOU 11 CD1AMLE A1001 927 1751 920 802 27 325 C HETATM 12 CD1BMLE A1001 9.922 7.351 20.868 0.50 9.68 C ANISOU 12 CD1BMLE A1001 633 1888 938 -17 18 182 C HETATM 13 CD2AMLE A1001 9.106 5.643 18.622 0.50 9.48 C ANISOU 13 CD2AMLE A1001 746 1193 1448 -218 9 402 C HETATM 14 CD2BMLE A1001 8.496 6.561 18.922 0.50 8.50 C ANISOU 14 CD2BMLE A1001 652 1275 1112 -238 103 258 C HETATM 15 C AMLE A1001 9.567 9.571 17.083 0.50 5.21 C ANISOU 15 C AMLE A1001 304 652 907 -20 -23 -2 C HETATM 16 C BMLE A1001 9.459 9.627 17.073 0.50 5.17 C ANISOU 16 C BMLE A1001 591 486 769 107 -183 -13 C HETATM 17 O AMLE A1001 10.234 10.633 17.344 0.50 5.59 O ANISOU 17 O AMLE A1001 326 509 1162 8 66 -88 O HETATM 18 O BMLE A1001 9.967 10.609 17.548 0.50 5.99 O ANISOU 18 O BMLE A1001 312 630 1199 99 -192 -147 O ATOM 19 N APHE A1002 8.249 9.627 16.719 0.50 4.20 N ANISOU 19 N APHE A1002 350 733 416 -20 14 -61 N ATOM 20 N BPHE A1002 8.236 9.497 16.542 0.50 6.13 N ANISOU 20 N BPHE A1002 425 576 1189 101 -27 -85 N ATOM 21 CA APHE A1002 7.482 10.940 16.586 0.50 4.84 C ANISOU 21 CA APHE A1002 392 454 884 -67 -78 13 C ATOM 22 CA BPHE A1002 7.347 10.603 16.472 0.50 4.44 C ANISOU 22 CA BPHE A1002 369 397 821 -72 5 89 C ATOM 23 C APHE A1002 6.395 10.745 17.569 0.50 4.97 C ANISOU 23 C APHE A1002 337 576 865 -88 -86 -8 C ATOM 24 C BPHE A1002 6.185 10.596 17.551 0.50 4.16 C ANISOU 24 C BPHE A1002 241 503 741 -26 39 72 C ATOM 25 O APHE A1002 5.567 9.732 17.487 0.50 4.38 O ANISOU 25 O APHE A1002 257 543 766 38 13 11 O ATOM 26 O BPHE A1002 5.258 9.842 17.312 0.50 6.45 O ANISOU 26 O BPHE A1002 299 848 1159 0 -13 -207 O ATOM 27 CB APHE A1002 6.791 11.167 15.251 0.50 5.73 C ANISOU 27 CB APHE A1002 494 591 963 87 29 84 C ATOM 28 CB BPHE A1002 6.807 10.546 15.052 0.50 5.80 C ANISOU 28 CB BPHE A1002 536 793 745 30 -46 86 C ATOM 29 CG APHE A1002 7.780 11.410 14.122 0.70 8.26 C ANISOU 29 CG APHE A1002 590 1469 894 62 -93 400 C ATOM 30 CG BPHE A1002 7.867 10.461 13.964 0.30 4.71 C ANISOU 30 CG BPHE A1002 505 631 545 -4 -114 170 C ATOM 31 CD1APHE A1002 8.348 10.387 13.390 0.70 10.86 C ANISOU 31 CD1APHE A1002 631 2298 952 382 64 106 C ATOM 32 CD1BPHE A1002 8.222 9.286 13.333 0.30 5.42 C ANISOU 32 CD1BPHE A1002 638 721 578 29 -26 42 C ATOM 33 CD2APHE A1002 8.122 12.713 13.821 0.70 11.72 C ANISOU 33 CD2APHE A1002 1207 1768 1213 -706 -377 632 C ATOM 34 CD2BPHE A1002 8.503 11.629 13.595 0.30 6.83 C ANISOU 34 CD2BPHE A1002 978 782 681 -253 -135 249 C ATOM 35 CE1APHE A1002 9.244 10.637 12.370 0.70 14.74 C ANISOU 35 CE1APHE A1002 941 3426 901 285 7 347 C ATOM 36 CE1BPHE A1002 9.194 9.284 12.354 0.30 6.02 C ANISOU 36 CE1BPHE A1002 589 1079 483 55 -63 -74 C ATOM 37 CE2APHE A1002 9.017 12.970 12.802 0.70 15.29 C ANISOU 37 CE2APHE A1002 1217 2944 1301 -958 -472 832 C ATOM 38 CE2BPHE A1002 9.475 11.629 12.615 0.30 7.46 C ANISOU 38 CE2BPHE A1002 832 1007 825 -502 -141 373 C ATOM 39 CZ APHE A1002 9.581 11.942 12.074 0.70 16.62 C ANISOU 39 CZ APHE A1002 899 3930 1112 -469 -180 848 C ATOM 40 CZ BPHE A1002 9.828 10.453 11.986 0.30 8.34 C ANISOU 40 CZ BPHE A1002 905 1655 420 -384 -20 -30 C HETATM 41 N AMLE A1003 6.196 11.597 18.592 0.50 5.43 N ANISOU 41 N AMLE A1003 505 811 625 -202 -114 45 N HETATM 42 N BMLE A1003 6.303 11.400 18.615 0.50 6.59 N ANISOU 42 N BMLE A1003 684 745 928 -251 146 -25 N HETATM 43 CN AMLE A1003 7.065 12.795 18.821 0.50 6.35 C ANISOU 43 CN AMLE A1003 446 694 1130 -68 115 -263 C HETATM 44 CN BMLE A1003 7.474 12.284 18.830 0.50 6.14 C ANISOU 44 CN BMLE A1003 642 670 883 -171 123 -151 C HETATM 45 CA AMLE A1003 5.051 11.288 19.547 0.50 6.24 C ANISOU 45 CA AMLE A1003 826 663 742 -20 8 152 C HETATM 46 CA BMLE A1003 5.238 11.412 19.643 0.50 5.50 C ANISOU 46 CA BMLE A1003 485 725 755 -281 56 -198 C HETATM 47 CB AMLE A1003 5.625 11.157 21.018 0.50 5.37 C ANISOU 47 CB AMLE A1003 516 779 622 36 102 -138 C HETATM 48 CB BMLE A1003 5.940 11.032 20.946 0.50 6.78 C ANISOU 48 CB BMLE A1003 681 853 890 -74 28 32 C HETATM 49 CG AMLE A1003 6.562 9.974 21.134 0.50 5.68 C ANISOU 49 CG AMLE A1003 592 797 641 -100 -47 53 C HETATM 50 CG BMLE A1003 6.653 9.738 21.167 0.50 7.14 C ANISOU 50 CG BMLE A1003 871 752 928 52 244 -9 C HETATM 51 CD1AMLE A1003 5.831 8.661 20.831 0.50 6.63 C ANISOU 51 CD1AMLE A1003 745 756 868 -165 24 334 C HETATM 52 CD1BMLE A1003 5.833 8.491 20.822 0.50 10.14 C ANISOU 52 CD1BMLE A1003 950 694 1978 62 -357 78 C HETATM 53 CD2AMLE A1003 7.154 9.917 22.545 0.50 7.69 C ANISOU 53 CD2AMLE A1003 694 1399 653 211 -21 127 C HETATM 54 CD2BMLE A1003 7.182 9.639 22.574 0.50 10.06 C ANISOU 54 CD2BMLE A1003 1163 1274 1157 470 -187 -116 C HETATM 55 C AMLE A1003 4.062 12.465 19.550 0.50 6.47 C ANISOU 55 C AMLE A1003 787 662 861 -138 86 47 C HETATM 56 C BMLE A1003 4.355 12.656 19.621 0.50 5.82 C ANISOU 56 C BMLE A1003 615 761 705 -250 106 -79 C HETATM 57 O AMLE A1003 3.333 12.566 20.420 0.50 8.16 O ANISOU 57 O AMLE A1003 1361 966 590 185 310 169 O HETATM 58 O BMLE A1003 3.947 13.119 20.732 0.50 16.43 O ANISOU 58 O BMLE A1003 2462 2624 786 1553 -127 -484 O HETATM 59 N ADPN A1004 4.155 13.249 18.516 0.50 6.98 N ANISOU 59 N ADPN A1004 1218 385 890 -37 278 80 N HETATM 60 N BDPN A1004 4.014 13.232 18.496 0.50 8.08 N ANISOU 60 N BDPN A1004 1413 678 795 92 143 -166 N HETATM 61 CA ADPN A1004 3.235 14.461 18.421 0.50 8.16 C ANISOU 61 CA ADPN A1004 953 388 1573 -43 218 3 C HETATM 62 CA BDPN A1004 3.224 14.382 18.316 0.50 6.50 C ANISOU 62 CA BDPN A1004 1185 516 620 -49 398 -55 C HETATM 63 C ADPN A1004 4.186 15.703 18.110 0.50 5.14 C ANISOU 63 C ADPN A1004 971 396 470 35 134 -49 C HETATM 64 C BDPN A1004 4.010 15.706 18.338 0.50 7.55 C ANISOU 64 C BDPN A1004 890 752 1056 -209 167 -72 C HETATM 65 O ADPN A1004 5.412 15.620 18.040 0.50 6.21 O ANISOU 65 O ADPN A1004 727 564 927 -204 -296 115 O HETATM 66 O BDPN A1004 5.229 15.544 18.355 0.50 11.74 O ANISOU 66 O BDPN A1004 981 776 2437 -54 26 463 O HETATM 67 OXTADPN A1004 3.544 16.753 18.063 0.50 5.88 O ANISOU 67 OXTADPN A1004 947 377 776 -119 393 -60 O HETATM 68 OXTBDPN A1004 3.438 16.795 18.346 0.50 13.31 O ANISOU 68 OXTBDPN A1004 905 458 3393 -86 888 -406 O HETATM 69 CB ADPN A1004 2.242 14.198 17.170 0.50 8.78 C ANISOU 69 CB ADPN A1004 670 460 2006 102 156 7 C HETATM 70 CB BDPN A1004 2.235 14.287 17.153 0.50 6.17 C ANISOU 70 CB BDPN A1004 670 378 1157 -222 433 -171 C HETATM 71 CG ADPN A1004 2.919 14.209 15.832 0.50 7.75 C ANISOU 71 CG ADPN A1004 568 425 1775 46 -214 -43 C HETATM 72 CG BDPN A1004 2.920 14.204 15.822 0.50 5.26 C ANISOU 72 CG BDPN A1004 465 697 718 -110 -20 -131 C HETATM 73 CD1ADPN A1004 3.135 15.372 15.120 0.50 8.02 C ANISOU 73 CD1ADPN A1004 422 523 1919 -13 -179 24 C HETATM 74 CD1BDPN A1004 3.149 15.347 15.083 0.50 6.01 C ANISOU 74 CD1BDPN A1004 815 667 667 -90 -43 -152 C HETATM 75 CD2ADPN A1004 3.350 13.022 15.274 0.50 8.27 C ANISOU 75 CD2ADPN A1004 768 554 1634 227 -386 -181 C HETATM 76 CD2BDPN A1004 3.345 13.006 15.282 0.50 5.43 C ANISOU 76 CD2BDPN A1004 575 665 700 31 -121 -149 C HETATM 77 CE1ADPN A1004 3.759 15.363 13.889 0.50 10.21 C ANISOU 77 CE1ADPN A1004 748 821 2077 116 -34 218 C HETATM 78 CE1BDPN A1004 3.777 15.301 13.855 0.50 6.19 C ANISOU 78 CE1BDPN A1004 596 938 677 -204 -139 18 C HETATM 79 CE2ADPN A1004 3.976 12.994 14.045 0.50 9.90 C ANISOU 79 CE2ADPN A1004 953 880 1703 495 -273 -62 C HETATM 80 CE2BDPN A1004 3.975 12.935 14.056 0.50 6.04 C ANISOU 80 CE2BDPN A1004 756 878 524 146 -218 -113 C HETATM 81 CZ ADPN A1004 4.183 14.167 13.347 0.50 10.41 C ANISOU 81 CZ ADPN A1004 878 1084 1757 -28 -147 -222 C HETATM 82 CZ BDPN A1004 4.193 14.092 13.337 0.50 6.42 C ANISOU 82 CZ BDPN A1004 712 1167 415 181 -136 -4 C TER 83 DPN A1004 HETATM 84 C MOH A1101 8.666 16.001 20.906 1.00 12.01 C ANISOU 84 C MOH A1101 1313 1604 1375 234 29 130 C HETATM 85 O MOH A1101 7.615 15.771 19.731 1.00 14.04 O ANISOU 85 O MOH A1101 1393 1437 2187 -560 -330 161 O HETATM 86 O HOH A1201 6.056 16.337 21.416 1.00 35.13 O ANISOU 86 O HOH A1201 3315 3114 6126 2014 2192 2827 O HETATM 87 O HOH A1202 5.021 14.179 22.772 0.64 22.61 O ANISOU 87 O HOH A1202 6471 835 773 641 683 -45 O HETATM 88 O HOH A1203 1.070 17.633 18.943 1.00 10.30 O ANISOU 88 O HOH A1203 695 1138 1846 169 181 763 O HETATM 89 O HOH A1204 0.899 13.588 21.113 1.00 14.38 O ANISOU 89 O HOH A1204 1417 2449 1271 -722 39 3 O HETATM 90 O HOH A1205 6.435 13.678 16.151 0.50 9.48 O ANISOU 90 O HOH A1205 978 1069 1340 8 -3 59 O HETATM 91 O HOH A1206 6.308 13.206 24.372 1.00 23.73 O ANISOU 91 O HOH A1206 3977 2288 2214 845 -343 -768 O HETATM 92 O HOH A1207 8.220 13.250 23.526 0.50 9.31 O ANISOU 92 O HOH A1207 1032 1094 1202 -15 219 243 O CONECT 1 3 5 CONECT 2 4 6 CONECT 3 1 CONECT 4 2 CONECT 5 1 7 15 CONECT 6 2 8 16 CONECT 7 5 9 CONECT 8 6 10 CONECT 9 7 11 13 CONECT 10 8 12 14 CONECT 11 9 CONECT 12 10 CONECT 13 9 CONECT 14 10 CONECT 15 5 17 19 CONECT 16 6 18 20 CONECT 17 15 CONECT 18 16 CONECT 19 15 CONECT 20 16 CONECT 23 41 CONECT 24 42 CONECT 41 23 43 45 CONECT 42 24 44 46 CONECT 43 41 CONECT 44 42 CONECT 45 41 47 55 CONECT 46 42 48 56 CONECT 47 45 49 CONECT 48 46 50 CONECT 49 47 51 53 CONECT 50 48 52 54 CONECT 51 49 CONECT 52 50 CONECT 53 49 CONECT 54 50 CONECT 55 45 57 59 CONECT 56 46 58 60 CONECT 57 55 CONECT 58 56 CONECT 59 55 61 CONECT 60 56 62 CONECT 61 59 63 69 CONECT 62 60 64 70 CONECT 63 61 65 67 CONECT 64 62 66 68 CONECT 65 63 CONECT 66 64 CONECT 67 63 CONECT 68 64 CONECT 69 61 71 CONECT 70 62 72 CONECT 71 69 73 75 CONECT 72 70 74 76 CONECT 73 71 77 CONECT 74 72 78 CONECT 75 71 79 CONECT 76 72 80 CONECT 77 73 81 CONECT 78 74 82 CONECT 79 75 81 CONECT 80 76 82 CONECT 81 77 79 CONECT 82 78 80 CONECT 84 85 CONECT 85 84 MASTER 201 0 4 0 0 0 0 6 50 1 66 1 END